REPLICEL LIFE SCIENCES INC. Cash Flows From Used In Operating Activities
REPLICEL LIFE SCIENCES INC. reported Cash Flows From Used In Operating Activities of -CAD 1.41 million for the 12-month period ending 2022-12-31, per its 20-F filed 2023-05-02.
Discontinued › Cash Flow › Operating Activities
ifrs-full:CashFlowsFromUsedInOperatingActivities · last filed 2023-05-02
| Period end | Cash Flows From Used In Operating Activities 12 month | Cash Flows From Used In Operating Activities 12 month as first filed |
|---|---|---|
| 2022-12-31 | -1.41M CAD 20-F · filed 2023-05-02 | |
| 2021-12-31 | -2.51M CAD 20-F · filed 2023-05-02 | |
| 2020-12-31 | -765.21K CAD 20-F · filed 2023-05-02 | |
| 2019-12-31 | -2.78M CAD 20-F/A · filed 2022-09-13 | |
| 2018-12-31 | 524.04K CAD 20-F · filed 2021-05-17 | -386.10K CAD 20-F · filed 2019-04-30 |
| 2017-12-31 | -5.39M CAD 20-F/A · filed 2021-03-31 | |
| 2016-12-31 | -3.54M CAD 20-F · filed 2019-04-30 | |
| 2015-12-31 | -4.36M CAD 20-F · filed 2018-05-11 |